Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effectiveness of the combination of the
drugs Everolimus and Letrozole compared to Tamoxifen and Medroxyprogesterone acetate in
treating endometrial cancer and to determine the types and severity of side effects caused by
treatment with these drug combinations.